SCN5A and ventricular fibrillation: The aim of our study was to associate some SCN5A polymorphic variants with coronary artery affliction in a special group of patients with non-LQTs ventricular fibrillation/flutter (VF) treated using an implantable cardioverter defibrillator which prevents the development of sudden cardiac death.